Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours Β· Estimated delivery Sep 1 - Sep 6
The vial of BPC-157 contained lead, the vial of TB-500 contained endotoxins, and the vial of CJC-1295 contained less than forty-two per cent of the advertised dose
5-Amino-1MQ is a research compound widely investigated in laboratory studies involving metabolic physiology, cellular energy regulation, NNMT-related pathways, adipocyte biology, mitochondrial function, and metabolic signaling
Theoretically, BPC-157 shows faster onset (4-6 days in animal models vs 2-6 weeks for human SSRIs), multi-system modulation rather than single-target effects, actual neuronal repair and regeneration (neuroprotection), no withdrawal syndrome in animals, and efficacy when given peripherally without extensive blood-brain barrier crossing
Martin, C
Strictly for in-vitro laboratory research only
